Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

8.44
Delayed Data
As of Jul 31
 -0.05 / -0.59%
Today’s Change
5.60
Today|||52-Week Range
11.90
+32.51%
Year-to-Date

Today’s Trading

Previous close8.49
Today’s open8.43
Day’s range8.32 - 8.60
Volume602,150
Average volume (3 months)477,701
Market cap$879.7M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+5.00%
Earnings growth (this year)+1.54%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)+928.53%
P/E ratioNM
Price/Sales21.28
Price/Book3.09

Competitors

 Today’s
change
Today’s
% change
NXTMNxStage Medical Inc+0.29+2.07%
KERXKeryx Biopharmaceuti...+0.23+2.97%
AMRIAlbany Molecular Res...+0.06+0.28%
SGMOSangamo BioSciences ...+0.35+3.98%
Data as of 3:59pm ET, 07/31/2015

Financials

Last reporting dateJuly 31, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$22.9M
Annual profit (last year)-$100.3M
Net profit margin-438.85%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
VP-Marketing, Commercial Strategy &
Operations
John Northcott
Corporate headquarters
The Woodlands, Texas

Forecasts